Phase 2 Study of Cemiplimab in Patients With Locally Advanced Basal Cell Carcinoma After Hedgehog Inhibitor Therapy: Long-Term Follow-up. J of Skin 2023, 7 (2), s178. https://doi.org/10.25251/skin.7.supp.178.